Brief: Karyopharm Therapeutics - Enters Forbearance Agreement And Waiver On Sept 10, 2026 - SEC Filing
11/09/2026 13:06
BRIEF-Karyopharm Therapeutics - Enters Forbearance Agreement And Waiver On Sept 10, 2026 - SEC Filing Sept 11 (Reuters) - Karyopharm Therapeutics Inc. KPTI.O:
KARYOPHARM THERAPEUTICS - ENTERS FORBEARANCE AGREEMENT AND WAIVER ON SEPT 10, 2026 - SEC FILING
KARYOPHARM THERAPEUTICS - DID NOT PAY $15.80 MILLION PRINCIPAL INSTALLMENT DUE SEPT 10, 2026 - SEC FILING
KARYOPHARM THERAPEUTICS - DOES NOT EXPECT TO PAY CASH INTEREST DUE SEPT 30, 2026 - SEC FILING
KARYOPHARM THERAPEUTICS - AGREES TO PAY $20 MILLION IN FEES AS FORBEARANCE CONSIDERATION - SEC FILING
KARYOPHARM THERAPEUTICS - TO PAY FEES IN SHARES OF NEWLY CREATED PREFERRED STOCK - SEC FILING
Source text: [ID:n0001193125-26-388621]
Further company coverage: KPTI.O